|
Abstract:
|
With the emergence of precision medicine, estimation of optimal individualized decision rules (IDRs) has attracted tremendous attentions in many scientific areas. Most existing literature has focused on finding optimal IDRs that can maximize the expected outcome for each individual. Motivated by complex individualized decision making procedures and the popular conditional value at risk, in this talk, I will introduce two new robust criteria to evaluate IDRs: one is focused on the average lower tail of the subjects’ outcomes and the other is on the individualized lower tail of each subject’s outcome. The proposed criteria take tail behaviors of the outcome into consideration, and thus the resulting optimal IDRs are robust in controlling adverse events. The optimal IDRs under our criteria can be interpreted as the distributionally robust decision rules that maximize the “worst-case” scenario of the outcome within a probability constrained set. Simulation studies and a real data application are used to demonstrate the robust performance of our methods.
|
